Next Article in Journal
Out of DSM: Depathologizing Homosexuality
Next Article in Special Issue
Testing the Predictive Validity and Construct of Pathological Video Game Use
Previous Article in Journal
Types of Relational Aggression in Girls Are Differentiated by Callous-Unemotional Traits, Peers and Parental Overcontrol
Previous Article in Special Issue
The Key to Individualized Addiction Treatment is Comprehensive Assessment and Monitoring of Symptoms and Behavioral Change
 
 
Article

Impulsivity and Stillness: NADA, Pharmaceuticals, and Psychotherapy in Substance Use and Other DSM 5 Disorders

Department of Psychiatry, Carolinas Healthcare System, 501 Billingsley Road, Charlotte, NC, 28211, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Andrew Doan
Behav. Sci. 2015, 5(4), 537-546; https://doi.org/10.3390/bs5040537
Received: 15 June 2015 / Revised: 2 November 2015 / Accepted: 8 November 2015 / Published: 26 November 2015
(This article belongs to the Special Issue Addictive Behaviors: Assessment and Treatment)
Pharmaceuticals and psychotherapy are commonly used in the management of impulsivity. The National Acupuncture Detoxification Association (NADA) protocol is an adjunctive therapy that involves the bilateral insertion of 1 to 5 predetermined ear needle points. One of the main benefits reported by patients, providers, and programs utilizing NADA is the sense of stillness, centering, and well-being. The induction of this attitude is seen as contributing to improved clinical outcomes including engagement and retention. The attitude of stillness is also suggestive of a pathway to mitigating impulsivity. Impulsivity is associated with substance use disorders and other DSM 5 diagnoses. Impulsivity has characteristics that are manifested clinically in behaviors such as disinhibition, poor self-control, lack of deliberation, thrill seeking, risk-taking. NADA holds promise as a useful treatment adjunct in the comprehensive management of disorders for which impulsivity is a prominent component. View Full-Text
Keywords: NADA; impulsivity; acudetox; mindfulness; pharmacology; adjunctive treatment; psychotherapy; substance use disorder; DSM NADA; impulsivity; acudetox; mindfulness; pharmacology; adjunctive treatment; psychotherapy; substance use disorder; DSM
Show Figures

Graphical abstract

MDPI and ACS Style

Carter, K.; Olshan-Perlmutter, M. Impulsivity and Stillness: NADA, Pharmaceuticals, and Psychotherapy in Substance Use and Other DSM 5 Disorders. Behav. Sci. 2015, 5, 537-546. https://doi.org/10.3390/bs5040537

AMA Style

Carter K, Olshan-Perlmutter M. Impulsivity and Stillness: NADA, Pharmaceuticals, and Psychotherapy in Substance Use and Other DSM 5 Disorders. Behavioral Sciences. 2015; 5(4):537-546. https://doi.org/10.3390/bs5040537

Chicago/Turabian Style

Carter, Kenneth, and Michelle Olshan-Perlmutter. 2015. "Impulsivity and Stillness: NADA, Pharmaceuticals, and Psychotherapy in Substance Use and Other DSM 5 Disorders" Behavioral Sciences 5, no. 4: 537-546. https://doi.org/10.3390/bs5040537

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop